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The program will celebrate the 50th year since our Congressional charter in 1964. Notable contributions to radiation protection policies and programs will be recalled, but the speakers will focus primarily on important challenges and opportunities to address the needs of the nation for the future. Presentations will be given by leading experts in each of the seven areas of protection to be covered with ample opportunities to ask questions verbally or textually.
• Session one addresses basic radiation protection criteria, epidemiology, radiobiology and risk. It includes presentations on integrating basic radiobiological science and epidemiological studies, challenges for radiation protection in space exploration, and the biological effectiveness of x and gamma rays as a function of energy.
• Session two covers nuclear and radiological security and safety concerns. The challenges facing an appropriate medical response to terrorist events involving improvised nuclear or radiological dispersal devices will be presented. After the emergency crisis has ended and the first responders have left, decision making for late-phase recovery following a nuclear incident with widespread radioactive contamination will be discussed.
• Session three explores both current and emerging issues in operational and environmental radiation protection. Specific topics include radiation safety and security of sealed sources (and how to protect the cowboys in the field), radiation safety associated with technologically-enhanced naturally-occurring radioactive material in the oil and gas industry (with a focus on fracking), and radiation safety in the burgeoning area of research and applications in nanotechnology.
• Session four focuses on radiation measurement and dosimetry. The first presentation emphasizes the continuing need for dosimetry and measurements in radiation protection. This will be followed by a presentation of the complex dosimetry needs and practical approaches being applied to the ongoing epidemiologic study of one million U.S. radiation workers and veterans.
• Session five opens with possibly the most important issue in radiation protection today and in medicine in particular (i.e., the protection for patients in diagnostic and interventional medical imaging). Following are presentations on protection of patients in radiation therapy and radiation protection of the developing embryo, fetus, and nursing infant.
• Session six covers the topics of radiation education, risk communication, outreach, and policy.
• Two concluding presentations address historical trends in radiation protection, policy and communications from 1964 to the present and the role played by national and international organizations in guiding and influencing U.S. radiation protection standards and regulations.
This year, NCRP celebrates 50 y of service to the Nation and the radiation protection community under its Congressional charter signed into law in 1964. However, the history of NCRP and its predecessor organizations date back to 1929, 34 y after the discovery of x rays and radioactivity. While the technology transfer that led to beneficial applications of these discoveries was likely one of the most rapid and profound in modern history, the development of consensus based safety standards to protect against the adverse effects of radiation (which were all too apparent to the many early radiation pioneers) was more gradual. Some members of the international community of scientists working with these sources were keenly interested in advancing and communicating proper radiation protection principles and practices. What would become NCRP was originally established in 1929 as the U.S. Advisory Committee on X-Ray and Radium Protection whose mission was to provide a U.S. consensus of scientific opinion on radiation protection matters to the newly formed International X-Ray and Radium Protection Committee, the predecessor of the International Commission on Radiological Protection (ICRP).
Dr. Lauriston S. Taylor chaired the Advisory Committee and served as the first official U.S. representative to ICRP. After World War II, development and utilization of new radiation technology in medicine and industry accelerated rapidly. In 1946 membership of the Committee was enlarged and its scope broadened to assure their activities would remain relevant. With these and other changes the Committee was renamed the National Committee on Radiation Protection (NCRP). In 1959, President Eisenhower issued an executive order establishing the Federal Radiation Council (FRC) to provide regulatory guidance on radiation protection at a national level. In recognition of NCRP's role in providing scientific advice and guidance on radiation protection policies and practices to FRC and others federal agencies, Congress chartered the NCRP in 1964 (Public Law 88-376) as "The National Council on Radiation Protection and Measurements" an independent, nonprofit organization to provide scientific guidance on radiation protection. Key elements of the NCRP charter include responsibilities to:
(1) collect, analyze, develop, and disseminate in the public interest information and recommendations
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NCRP: Achievements of the Past 50 Years and Addressing the Needs of the Future about radiation protection, measurements, quantities and units; (2) provide a means by which other scientific organizations with related interest and concerns may cooperate for effective utilization of their combined resources; (3) develop basic concepts about radiation quantities, units, and measurements and their application to radiation protection; and (4) cooperate with the ICRP and other international and national organizations. A set of bylaws was developed that included the election of a President and other officers of the corporation, 75 members of Council (later increased to 100 in 1997) comprised of scientific experts in a broad range of disciplines with relevance to radiation protection, and a Board of Directors.
Since the establishment of its Congressional charter, NCRP has had five productive decades as evidenced by the publication of 174 reports and 90 other documents, including commentaries, statements, and conference proceedings (57 of these documents were published in the last 10 y). In addition, many of the current U.S. radiation protection standards can trace their origin to recommendations made in these NCRP publications (e.g., Report No. 116) . Together, these reports have provided guidance and recommendations on a broad array of topics relevant to the science of radiation protection.
The majority of the work of NCRP is accomplished through its scientific committees (SC). The SCs are organized under program area committees (PACs) or advisory committees which help identify important radiation protection issues and topics for which a report by a SC composed of relevant subject matter experts would be of value. Using the lessons from the past to help guide our future, NCRP has embarked on a number of initiatives (both scientific and operational) to assure Council and staff will be well prepared to continue its exemplary service to the Nation. Examples of operational initiatives include:
• improvements in NCRP's utilization of the expertise of Council members;
• modifications to our committee structure to improve efficiency and allow for greater cross-discipline communications;
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• enhancements to our web presence and the use of social media to keep up with trends in information access; • collaborate with other organizations to encourage young scientists to become engaged in professional development of scientific disciplines related to radiation protection; • developing a deeper understanding of the radiation protection challenges faced by NCRP's federal agency sponsors; reviewing current radiation protection guidance for the United States; • closer coordination with our national and international partners; and • rightsizing and timely preparation of reports and streamlining the Council report review process.
Council members and any other interested parties are encouraged to contact NCRP leadership with any suggestions for improving NCRP's ability to fulfill its mission.
NCRP has recently broadened its scope to respond to some of the pressing needs of today's radiation protection environment. NCRP's role in the WARP initiative (Where are the Radiation Professionals: A National Crisis?) to help address the rapidly diminishing workforce of radiation professionals and NCRP's engagement in epidemiological research to extend our knowledge of the potential health effects of low dose radiation by way of the Million Worker Study are just a few of such visionary activities.
While many advances have been made, there are still many questions of importance to radiation protection that have not been fully resolved despite years (sometimes decades) of effort. NCRP will play an important role in helping to develop a consensus view regarding complex issues such as:
• estimating and effectively communicating the health risk from "low dose" radiation;
• implications of nontargeted effects, the concerns about sensitive subpopulations; • biological effectiveness of low energy photons; • challenges of applying justification and optimization in diverse environments such as medical imaging and environmental remediation of contaminated sites; • long-term storage and monitoring of high level radioactive waste • practical considerations and benefits from harmonization of units and dose limits; • risks of space travel;
• implications of nanotechnology in radiation safety; and • many others that will no doubt extend far into the 21st century.
These uncertainties will continue to influence the cost and benefits derived from the ever expanding use of radiation in everything from medical imaging and cancer treatment to manufacturing and homeland security. There will be a continuing need for NCRP to identify the principles upon which radiation protection is to be based and to provide guidance on best practices for the practical application of those principles for the many beneficial uses of radiation in society. The unique and invaluable resource that is NCRP is in large part due to the selfless dedication and numerous contributions of its Council and SC members. The multidisciplinary composition of these leading experts' and their collective input on complex questions provides a unique synergy that result in a comprehensive and well balanced approach to addressing current and future radiation protection challenges. Subsequent presentations covering a broad range of relevant topics will review sentinel accomplishments of the past as well as current work and future challenges that are in keeping with NCRP's mission to advance the science of radiation protection in the public interest. On the one hand, there is a quite extensive set of epidemiology studies conducted for a range of different exposure scenarios and in some cases at doses that can be considered to be in the low dose range (<100 mGy). There are uncertainties associated with these studies, for example with the dosimetry, potential confounding factors, and models used for extrapolation to effects at environmental doses and for chronic exposures. On the other hand, there is extensive literature on the effects of radiation at the animal and cellular levels. In addition, there is an expanding knowledge of the underlying mechanisms of disease formation (both cancer and noncancer). Here also there are uncertainties associated with the ability to extrapolate from these studies to predict adverse health outcomes in radiation-exposed human populations. A significant concern is that these two areas of study have rarely been linked to support each other -to enhance low dose/low dose-rate extrapolation and reduction of uncertainty in risk estimates. A significant reason for this is that basic radiobiology research generally has not been designed to support the risk assessment process but rather it is used post facto in an attempt to provide such support. In general, this is not a very satisfactory approach. It is proposed that there be an area of research that uses experimental designs that would provide specific types of data to support the epidemiology and thereby would enhance the radiation risk assessment process. An unresolved question in evaluating the risk of cancer in humans from exposure to low linear-energy transfer (LET) radiation (i.e., photons and electrons) is the dependence of the biological effectiveness on energy. This dependence is relevant for estimating risks of cancer from exposure to low-LET radiation at the lower energies used in mammography as well as certain sources of occupational and public exposure. Because of the broad importance of this topic to the basic responsibilities and interests of NCRP, the Council created a scientific committee to evaluate this question. Other expert groups and investigators have also considered this question, and several have concluded that the biological effectiveness of lowerenergy low-LET radiation based on radiobiologic data and biophysical considerations may be two or more times greater than for higher-energy low-LET radiation. However, biological systems used in the experiments and biophysical analysis provide only indirect evidence and may not be strictly applicable to cancer in humans, particularly considering that there are many types of cancer. Epidemiologic studies that, in theory, could demonstrate that lower-energy photons and electrons are biologically more effective than highenergy photons are inherently difficult to conduct when very large study populations and highly accurate estimates of cancer risks are required to observe a presumably small effect. Because of the enormous complexity of the phenomena that are involved in the development of cancer following exposure to ionizing radiation, it is unlikely that any single area of study can provide a clear understanding of the relative biological effectiveness of different energy radiations. For these various reasons, an important aspect of the evaluation by SC 1-20 is the combined assessment of multiple lines of evidence and their related uncertainties. SC 1-20 is basing its analysis on five different lines of evidence:
• microdosimetric calculations;
• studies of damage to DNA, including theory, calculations, and experimental data; • radiobiologic studies in cellular systems; • radiobiologic studies in animal systems; and • human epidemiologic studies. Accordingly, the Committee has developed a means of assessing a probability density function (PDF) of the biological effectiveness for selected energies (photons of energy ~1.5 keV, ~15 to 30 keV, ~40 to 60 keV, ~50 to 150 keV, and the spectrum of electrons produced in beta decay of tritium) using all available information from the different lines of evidence. Methods for this purpose have been drawn from the field of probability assessment
Biological Effectiveness of Photons and Electrons as a Function of Energy Steven L. Simon National Cancer Institute
Abstracts: Monday, March 10 11 that utilizes the elicitation of expert input and the synthesis of data from multiple sources of information via Bayesian analysis. In this context, the PDF is intended to represent the current state-of-knowledge about the relative biological effectiveness of the specified low-LET radiations. While the most recent publications in radiation research will provide SC 1-20 with only very limited data that previous expert groups and other investigators did not evaluate, the derivation of a composite PDF based on multiple lines of evidence may provide a unique contribution that can be used to assess the uncertainty in estimates of radiation-related cancer risk. This presentation will summarize the current status of the analysis by SC 1-20. • publishing in the peer review literature; and
• making the information understandable and usable for responders who may not have sophisticated training in the radiation sciences.
The knowledge and expertise needed ranges from radiation physics, physical models of detonations, radiation normal tissue injury, medical countermeasure development, mass casualty planning, triage/scarce resource allocation, radiation epidemiology, information management and technology and emergency management. In the aggregate, what we call "REMS" (Radiation Emergency Management System) has been developed which is a complex system that is continuously evaluated and improved. Health and medical planning and response for radiological and nuclear incidents have been helped by contributions from NCRP. Indeed, both the research and service missions of the federal agencies have expanded, providing new opportunities for investigation and implementation by government, academia, and the private sector. Furthermore, international collaborations have been strengthened and there have been spin-offs that could benefit cancer treatment. This presentation will review how the REMS approach was developed and how it is continuing to evolve. The radiation teams were involved in responding to the disaster in Japan in 2011, the experience from which has lead to the proposal of a "Medical Decision Model" for effectively managing rapidly evolving radiological and nuclear incidents. Newer issues for consideration are estimating and potentially mitigating risk from radiation-induced cancer and developing a comprehensive "National Concept of Operations."
Response to an Improvised Nuclear Device or a Radiological
11:35 am
In the United States, effort on radiological emergency preparedness has focused primarily on initial responses to an incident; the guidance on the more complex, longterm issues relating to the late-phase recovery has been lacking. It is clear from the recent major accidents at Chernobyl (Ukraine 1986) and Fukushima (Japan 2011) nuclear power plants that the magnitude of the radiological impact can affect extended areas and last for many years, thus making planning for recovery a necessary component to the overall response. Similar challenges likewise may be encountered in the illicit incidents involving the use of radioactive or nuclear material such as those could be posed by a radiological dispersal device (RDD) or improvised nuclear device (IND). In 2010 NCRP established a scientific committee (SC 5-1) to prepare a comprehensive study that establishes the framework of and recommends an approach to optimizing decision making in late-phase recovery from major nuclear or radiological incidents. The study, to be published as There is also the possibility that sealed sources may be (or threatened to be) used for terrorist purposes and disruptive opportunities.
Until fairly recently, generally-licensed sealed sources and devices received little, if any, regulatory oversight, and were often forgotten, lost, or unaccounted for. Nonetheless, generally licensed devices can contain fairly significant quantities of radioactive material (e.g., 500 mCi of 137 Cs, 1,000 mCi of 241 Am), and there is some dose potential associated with activities of this magnitude if a device is treated in a way that it was never designed.
Industrial radiographers use and handle large, high-dose sealed sources in the field with a high degree of independence and minimal regulatory oversight. Failure to follow operational procedures and properly handle radiography sources can and has resulted in serious injuries and death. Industrial radiographers have experienced a disproportionately large fraction of incidents that result in unintended exposure to radiation. NCRP has not previously provided overarching guidance on the radiation safety aspects of the fabrication, certification, use and control of sealed radioactive sources. Program Area Committee 2, Operational Radiation Safety, is preparing a report to provide comprehensive guidance on the radiation safety of sealed radioactive sources from "cradle to grave." Recommendations will be provided on the definition of a sealed radioactive source, design and fabrication, acquisition, safe handling, storage, tracking, and control of sealed sources. The report will also present a set of "lessons learned" regarding what has gone wrong with sealed sources, what caused those events, and what could be done to prevent them in the future. This presentation will provide an overview of the Commonwealth of Pennsylvania's experiences and ongoing studies related to technologically-enhanced naturallyoccurring radioactive material (TENORM) in the oil and gas industry. It has been known for many years that Pennsylvania's geology is unique, with several areas having relatively high levels of natural uranium and thorium. In the 1950s a few areas of the state were evaluated for commercial uranium production. In the late 1970s scoping studies of radon in homes prompted the Pennsylvania Department of Environmental Protection (DEP) Bureau of Radiation Protection (BRP) to begin planning for a larger state-wide radon study. The BRP and Oil and Gas Bureau also performed a TENORM study of produced water in the early 1990s for a number of conventional oil and gas wells. More recently BRP and the Bureau of Solid Waste developed radiation monitoring regulations for all Pennsylvania solid waste disposal facilities. These were implemented in 2001 prompting another evaluation of oil and gas operations and sludges generated from the treatment of conventional produced water and brine, but mainly focused on the disposal of TENORM solid waste in the state's Resource Conservation and Recovery Act Subtitle D landfills. However since 2008, the increase in volumes of gas well wastewater, and levels of 226 Ra observed in the unconventional shale gas well flow-back frac water, has compelled DEP to fully re-examine these oil and gas operations. Specifically, with BRP in the lead, a new TENORM study of oil and gas operations and related wastewater treatment operations has been initiated. This study began in early 2013, and will examine the potential public and worker radiation exposure and environmental impact, as well as re-evaluate TENORM waste disposal. This presentation will summarize conventional and unconventional oil and gas well operations, geology and respective uranium/ thorium content, radium content in oil and gas wastewater, treatment solids, radon in natural gas, the scope of other TENORM issues in the state, regulatory framework, national regulations and guidance, as well as, provide an overview of past and status of ongoing TENORM studies in the Commonwealth.
Radiation Safety of Sealed Radioactive Sources
2:35 pm
NCRP has established Scientific Committee 2-6 to develop a report on the current state-of-knowledge and guidance for radiation safety programs involved with nanotechnology. Nanotechnology is the understanding and control of matter at the nanoscale, at dimensions between ~1 and 100 nm, where unique phenomena enable novel applications. In recent years manmade nanoparticles, including those that are radioactive, have been developed and incorporated into a wide variety of engineered nanomaterials. Applications are being found in a broad range of medical, industrial, educational and consumer products; their use is rapidly expanding. In some cases, radiation is being used to create or alter materials at the nanoscale. Nano-engineered structural materials, metals, coatings, coolants, ceramics, sorbents and sensors may be particularly enabling in radiation-related applications.
Areas of interest for the report include programs where radiation or radioactivity are being used to characterize or alter materials at the nanoscale, to radiolabel nanomaterials for tracking or evaluation of physicochemical and biological behavior, or to use nano-formulated materials in situations involving radiation or radioactivity. The focus is on operational information of practical value to radiation safety officers, operational health physicists, dosimetrists, workers, management, and regulators. Knowledge gaps regarding information needed to implement appropriate radiation safety programs in these settings will be identified.
Questions of interest include how traditional health physics program practices may need to be modified to provide adequate safety for working with radioactive nanomaterials or working with radiation in nanotechnology applications. To the extent possible, the report will provide guidance on contamination control, engineered and administrative controls, personal protective equipment including respiratory protection, training, waste disposal, and emergency response. The report will also provide specific guidance on conducting internal dosimetry programs if radioactive nanomaterials are being handled. Possible differences in the biological uptake and in vivo dissolution or translocation of radioactive nanoparticles, compared to more commonly encountered micrometer-sized particles, may impact the design and conduct of dosimetry programs. In particular, how nanometer-sized particles are addressed in current respiratory tract and systemic dosimetry models will be evaluated. Model parameters and considerations including deposition efficiency, total and regional retention patterns, and cells and tissues at risk; dose calculation methods; and the potential for multifactorial biological effects from radiation, chemical, and physical particle properties of the nanoparticles are also being considered. It is intended that the report will also inform the broader nanotechnology knowledge infrastructure community. It has always been recognized that radiation measurements and dosimetry play a crucial role in developing radiation protection programs for workers and the public particularly as they relate to mitigating potential health risks from exposure to NCRP has always devoted significant resources to these scientific disciplines in terms of its published reports, and it is anticipated that this emphasis will continue. This includes focus on both external and internal radiation exposure as well as radiation and radioactivity measurement methodology. NCRP, as part of its management of scientific activities, has designated Program Area Committee (PAC) 6 to focus on both radiation measurements and dosimetry (membership comprises all authors). This presentation will briefly describe how radiation measurements and dosimetry were addressed historically in terms of NCRP activities and reports, how the emphases have changed over the years, and how NCRP has worked effectively with other radiation protection organizations such as the International Commission on Radiological Protection to leverage its expertise in advancing the science of measurements and dosimetry, particularly the latter. For example, recent reports have focused on the state-of-theart in radiation dose assessment as well as elucidating methodologies for evaluating uncertainties in assessing radiation doses from exposure to both external and internal sources of radiation.
Currently the activities of PAC 6 in dosimetry have focused on working with other PACs, bringing its dosimetry and measurement expertise to address larger radiation protection issues, such as radiation protection issues relating to exposure to radioactive nanoparticles, contributing to the development of comprehensive dose assessment methods to deal with the wide range of exposures encompassed by various populations (e.g., those being studied in the Million Worker Study) and performing a quality assurance function for dose assessments (i.e., Operation Tomodachi) performed by other agents and agencies.
Moving forward, it is clear that the needs for expertise in radiation measurements and dosimetry will not diminish, but will continue to be associated with larger scope projects in which measurements and dosimetry play pivotal roles. Thus it is anticipated that collaborations with other PAC activities will continue. In addition, there are also initiatives in which PAC 6 is playing a lead role. These include:
• developing guidance on frameworks for licensing biophysical devices and/ or biological and pharmacological endpoints for biomarkers of radiation exposure and radiation-induced disease; • elucidating data collection strategies and dose assessment methods for following up potentially exposed members of the public; • revising the classic NCRP Report
No. 58 on radioactivity measurements; and • exploring emerging issues in measurement and dosimetry relating to medical radiation treatments and diagnostics.
3:45 pm
The primary aim of the epidemiologic study of one million U.S. radiation workers and veterans (the Million Worker Study) is to provide scientifically valid information on the level of radiation risk when exposures are received gradually over time, and not acutely as was the case for Japanese atomic-bomb survivors. The primary
Dose Reconstruction for the Million Worker Epidemiological Study
Andre Bouville National Cancer Institute outcome of the epidemiological study is cancer mortality but other causes of death such as cardiovascular disease and cerebrovascular disease will be evaluated. The success of the study is tied to the validity of the dose reconstruction approaches to provide unbiased estimates of organ-specific radiation absorbed doses and their accompanying uncertainties. The dosimetry aspects for the Million Worker Study are challenging in that they address diverse exposure scenarios for diverse occupational groups being studied over a period of up to 70 y. The dosimetric issues differ among the varied exposed populations that are considered: atomic veterans, U.S. Department of Energy workers exposed to both penetrating radiation and intakes of radionuclides, nuclear power plant workers, medical radiation workers, and industrial radiographers. While a major source of radiation exposure to the study population comes from external gamma-or x-ray sources, for certain of the study groups there is a meaningful component of radionuclide intakes that require internal radiation dosimetry measures.
Scientific Committee 6-9 has been established by NCRP to produce a report on the comprehensive organ dose assessment (including uncertainty analysis) for the Million Worker Study. The Committee's report will cover the specifics of practical dose reconstruction for the ongoing epidemiologic studies with uncertainty analysis discussions and will be a specific application of the guidance provided in NCRP Reports Nos. 
Introduction of the Lecturer
Milton J. Guiberteau
There have been remarkable advances in the knowledge of radiation effects and the philosophy of radiation protection over the last half century. No one single person was responsible for this. Most advances have been due to a number of remarkable scientists and physicians (giants) who laid the groundwork, did research, and who mentored and trained us. I have had the good fortune to interact with many of these giants and get to know them on a personal basis. Over the past 50 y we have seen radiobiology progress from single-hit theory to epigenetic effects, watched remarkable growth in medical radiation applications, gone from concern about genetic effects to elucidation of specific tumor risks, seen continued spectacular accidents from various causes, gone from Cold War fallout concerns to issues regarding terrorism and expansion of nuclear weapon countries, seen nuclear power expand then wane and grappled with the legacy issues of nuclear waste. Success in the future will depend upon our current group of "giants" and their ability to identify and train the next generation.
6:00 pm
Reception in Honor of the Lecturer
Sponsored by Landauer, Inc. The radiology community (radiologists, medical physicists, radiologic technologists, and interventional proceduralists) has led the educational and awareness efforts to reduce radiation dose to our patients through effective collaborations that bridge traditional specialty silos and reach all stakeholders. These successful collaborations have included both vendors and regulators, with the overarching goal of dose reduction. Dose reduction to patients often raises overall safety awareness and lowers occupational doses as well. It is critical that the entire radiology community continue to act as leaders in these efforts in radiation safety for both employees and patients. In order to be successful, we must understand the current state-of-the-science and the growing, worldwide, multimedia resources that are available to us. There is little time or budget for us to recreate training materials or risk communication information that may already exist.
On the Shoulders of Giants: Radiation Protection Over
In order to create a strong environment of radiation protection for patients (and for employees), there must also be a strong health system culture of safety. We will discuss multiple elements and training that create a safety culture. Note that safety is necessary but not sufficient to ensure quality healthcare. Radiology departments and healthcare systems focus on safety culture and metrics often based on external requirements or demands such as from the Joint Commission, regulatory agencies, consumer groups, and payers. Increasingly, radiation metrics are included in determining the quality of an imaging department and overall health system.
Together with the increasingly fast-paced and demanding healthcare environment and sharp focus on quality, it has never been more important to understand how to achieve better quality care for radiology departments. That must begin with radiation protection of our patients. We must measure quality for many customers that include patients, referring providers, and many others. How do we show that we are providing, monitoring, and improving quality service in radiology? This presentation will briefly describe the rationale and methods for using collective learning tools that document radiation protection of patients in diagnostic and interventional imaging. These tools include the use of imaging modality registries such as the Computed Tomography Dose Index Registry, peer review of imaging reports, the use of clinical decision support, and guidelines. • provide the current state-of-the-science regarding cancer risk from medical procedures using ionizing radiation; • understand the three basic radiation protection principles for patients and for radiation workers; • recognize key methods to build a safety culture in radiology; • understand both qualitative and quantitative metrics in a radiology safety program;
Protection of Patients in Diagnostic and
• provide examples of quality assurance and improvement projects based on a safety event and that promote a culture of safety; and
• understand the radiation dose reduction goals and educational materials for all stakeholders involved in imaging children (Image Gently ® ), in imaging adults (Image Wisely ® ) and in efforts to more appropriately use testing (Clinical Decision Support and the Choosing Wisely ® Campaign).
10:10 am
From its inception, NCRP has contributed much to the field of radiation therapy. Guidance from NCRP encompasses radiation protection of workers, prenatal exposure, risk of damage to normal tissues, reference dosimetry, neutron contamination in therapeutic beams, and facility shielding. Radiation protection of the patient, staff, and members of the public must be reassessed with the introduction of each new technology into radiation therapy, which in turn underscores the need to improve our basic scientific understanding.
Radiation protection concerns include secondary cancers due to radiation to uninvolved tissues, damage to the fetus, damage to implantable electronic devices (e.g., pacemakers and implantable cardioverter defibrillator), and protection of staff and members of the public near radiation therapy equipment.
These concerns must be addressed in ways appropriate to the technology in use.
Technological developments in radiation therapy include brachytherapy using either superficial application or temporary or permanent implantation, therapy with radioactive drugs, conventional and conformal external beams (photons or electrons), higher energy beams (10 MV) where neutrons contribute, intensity modulated radiation therapy and volumetric arc therapy, small field delivery (via stereotactic radiosurgery or stereotactic body radiation therapy), total body irradiation and total skin electron therapy, specialized equipment (such as Tomotherapy ® , CyberKnife ® , and 60
Co with onboard magnetic resonance imaging), and particle therapies using protons or heavier ions.
This in turn leads to consideration of the science underlying radiation protection and measurement. Scientific concerns include dose risk, both in terms of prompt effects (normal tissue morbidities such as moist desquamation and impaired salivary function) and delayed effects such as secondary cancers and cardiovascular disease. A second underlying scientific concern is dose calculation, which includes absolute dosimetry, extra-focal and leakage radiation, and neutron contamination in beam therapy. A third concern involves dose measurement, both in the case of brachytherapy sources and external beam. A final concern is the engineering of safety and shielding, which
Protection and Measurement in Radiation Therapy
Steven G. Sutlief University of Washington Medical Center includes equipment design, personal shielding, and facility shielding.
Historical milestones include the formation of several radiation protection organizations in the late 1920s, including the predecessor of NCRP. Through the efforts of these organizations and other professional societies, guidance has been offered to the user community and members of the public on the issues listed above. During the ensuing years, refinements were made both to the quantities used in radiation protection and to the dose limits for workers and members of the public. Most of the primary concerns were identified early in the history of radiation protection and now undergo periodic revision.
Current trends in radiation protection are driven by the rapid commercial development of new radiation therapy technologies, improved science of normal tissue susceptibilities to radiation, and the evolving technology of implantable devices. Foremost among current technological advancements are the use of image guidance and wider availability of proton therapy. Other recent developments include intra-arterial delivery of radioactive microspheres for treating liver lesions, radiolabeled monoclonal antibodies for treating certain lymphomas, and the very recent introduction of therapeutic radiopharmaceuticals incorporating alphaemitting radionuclides.
Future developments will likely include increased use of imaging for assessment and treatment positioning and wider clinical use of molecularly-based disease assessment and treatment strategies. While the conformity of radiation dose continues to undergo incremental refinements, greater gains may be made by assessing patient-specific radiation biology for the purpose of patient selection, so that radiation is given only to those patients likely to benefit from it, as well as broader use of monoclonal antibodies or coupling of radiotherapy with immunotherapy.
This presentation will review historical trends in radiation protection and measurement, describe the current status, and suggest future directions likely to be most fruitful.
10:35 am
Scientific knowledge has increased and public concerns have changed in the 37 y since NCRP Report No. 54, Medical Radiation Exposure of Pregnant and Potentially Pregnant Women (1977) was published. The scope of Report No. 174, Preconception and Prenatal Radiation Exposure: Health Effects and Protective Guidance (2013) covers both ionizing radiation and nonionizing sources. The ionizing radiation sources discussed consist predominantly of low linear-energy transfer radiation.
• Gamete radiation: There is no convincing direct evidence of germline mutation manifest as heritable disease in the offspring of humans and attributable to ionizing radiation, yet radiation clearly induces mutations in microbes and somatic cells of rodents and humans, and transgenerational effects in irradiated drosophila and mice are established. It would be imprudent to ignore the possibility of human germcell mutation, especially since progress in human genetics and genomics promises quantum improvements in being able to address the issue in the future.
• Pregnancy risks from ionizing radiation: The background rate for major
Protection of the Developing Embryo and Fetus from Ionizing Radiation Exposure Robert L. Brent Alfred I. duPont Institute Hospital for Children
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NCRP: Achievements of the Past 50 Years and Addressing the Needs of the Future congenital malformations is ~3 % (i.e., in the absence of radiation exposure about 3 of every 100 children born have a recognizable major birth defect). Pregnancy loss (spontaneous abortion, miscarriage) in women who know they are pregnant occurs in 15 % of pregnancies with a wide standard deviation. Doses to the embryo estimated to be in the range of 0.15 to 0.2 Gy during the preimplantation and presomite stages may increase the risk of embryonic loss. However, an increased risk of congenital malformations or growth retardation has not been observed in the surviving embryos. These results are primarily derived from mammalian animal studies and are referred to as the "all or none phenomenon." The potential tissue reactions of ionizing radiation (previously referred to as deterministic effects) are congenital malformations, mental retardation, decreased intelligence quotient, microcephaly, neurobehavioral effects, convulsive disorders, growth retardation (height and weight), and embryonic and fetal death (miscarriage, stillbirth). All these effects are consistent with having a threshold dose below which there is no increased risk. Based on animal studies, the no-adverse-effect level (dose to the embryo or fetus) in humans is estimated at 0.2 Gy for anatomical congenital malformations during a very short period during early organogenesis, and is higher for most other tissue reactions. Doses to the embryo or fetus due to radiation exposure to the maternal chest, extremities, neck and head from diagnostic x-ray procedures do not exceed 0.1 Gy and are thus less than the noadverse-effect level for any of the previously mentioned tissue reactions.
• Radiation carcinogenesis: The risk of cancer in offspring that have been exposed to diagnostic x-ray procedures while in utero has been debated for 55 y. High doses to the embryo or fetus (e.g., >0.5 Gy) increase the risk of cancer. Most pregnant women exposed to x-ray procedures and other forms of ionizing radiation today received doses to the embryo or fetus <0.1 Gy. The risk of cancer in offspring exposed in utero at a low dose such as <0.1 Gy is controversial and has not been fully resolved. Nevertheless, diagnostic imaging procedures utilizing ionizing radiation that are clinically indicated for the pregnant patient should be performed because the clinical benefits outweigh the potential oncogenic risks.
• Mitigation of ionizing radiation risk for pregnant or potentially-pregnant women: Prior to any medical ionizing radiation exposure, it is important to assess if the woman is pregnant, or if there is the possibility that she may be pregnant. The conventional methods of pregnancy assessment range from verbal communication to a highly-sensitive biochemical assay of human chorionic gonadotropin produced by the developing placenta. Nevertheless, women should be considered potentially pregnant if she thinks she may be pregnant.
• Communicating benefits and risks:
Women exposed to radiation during pregnancy and members of their families often seek counseling about the associated radiation exposure and present with various levels of anxiety. In such circumstances it is important that the counselor be well versed in the potential adverse consequences associated with the various levels of radiation exposure. The past 50 y have seen substantial developments in radiation epidemiology, technology, dosimetry, regulations and protection efforts. During the last five decades, radiation communication has also evolved, growing more sophisticated as communication science and practice have advanced and matured. This talk will cover the trends in radiation protection over the past 50 y, illustrated by progress in science and practice of risk communication and changes in societal expectations, and examine challenges that confront radiation risk communication in the future.
Early radiation communication efforts largely adopted a paternalistic approach, featuring experts whose purpose was to educate members of the public about the risks and benefits of radiation. Based on studies in communication and research, this model has been largely replaced by a more collaborative process, structured around discussions among radiation experts, stakeholder groups, and community representatives. Concurrently, communications technology since the mid20th century has been transformed by, among other things, the explosion in cellular devices and the rise of social media. These have been both a boom and challenge for radiation risk communication efforts.
This talk will examine the ways in which risk communication has transformed since NCRP was chartered by the U.S. Congress. From the mid-20th century focus on mitigating potential nuclear attacks and civil defense to the early 21st century focus on preparedness, medical radiation, and response to the accident at Fukushima, the type, nature and technology of communications has changed greatly. NCRP and its members should be prepared for addressing both emerging issues of radiation protection and new, innovative ways of communicating about radiation benefits, risks and policies.
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The early history of radiation protection recommendations in the United States is intertwined with similar efforts in Europe. Our knowledge of radiation-related health risk has evolved and improved over time.
As indicated by the names of the early organizations, the first recognized threats from radiation exposure came from radium and x rays. Early radiation protection advice concentrated on preventing observed deterministic effects (e.g., skin erythema). In the 1950s, concern had shifted to preventing genetic effects, which were thought to be possible at doses lower than the levels associated with observable tissue damage. Major epidemiological studies, such as the Life Span Study (LSS) of Japanese atomicbomb survivors, failed to show evidence of genetic effects, but did show excess cancers in people exposed to a few hundred millisieverts. More recent follow-up of the LSS cohort and other large epidemiological studies have shown positive dose response correlations around, and in some cases below, 100 mSv, so that cancer risk is now the limiting factor in setting radiation protection regulations. Both the U.S. National Academy of Sciences (NAS) and the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) recommend using a linear nothreshold model for estimating excess cancers at low doses. More recently, scientists have begun to explore noncancer endpoints, such as circulatory disease, and to suggest that these effects too might result from exposures to moderate doses of radiation. Science continues to be a driving force in the evolution of the system of radiation protection.
The considerable degree to which the system of radiation protection is practiced consistently around the world is largely There are many exceptions to this flowchart and many nations tailor the flow path to their unique needs. In the United States, the path from new science and recommendations to new regulations must follow the process laid out in the Administrative Procedure Act, which provides the public an opportunity to review and comment on proposed regulations before they are adopted. Federal agencies must be given statutory authority to issue regulations, and their regulations will reflect the requirements of the particular statute they are using. He has published over 160 peer-reviewed journal articles, coauthored/edited 14 books/book chapters, and served as coauthor on two NCRP reports, two ICRP publications, and two MIRD monographs. Dr. Bolch has managed a broad research program including (1) National Cancer Institute and U.S. Department of Energy funded projects to construct high-resolution models of the skeleton to support dose-response studies in radionuclide therapy and radiation epidemiology, (2) National Institute of Biomedical Imaging and Bioengineering funded projects to develop scalable nonuniform rational B-spline-based and voxel-based computational phantoms of adult and pediatric patients and associated software for organ dose assessment in nuclear medicine, computed tomography, interventional fluoroscopy, and radiotherapy, (3) private company funded projects to develop stereotactic kilovoltage x-ray treatments for age-related macular degeneration and glaucoma, and (4) Centers for Disease Control and Prevention funded projects in stochastic modeling of worker inhalation and gamma-ray exposures following radiological accidents and potential terrorist events.
Andre Bouville was born and educated in France. He came to the United States in 1984 to work for the National Cancer Institute (NCI). His initial assignment was to estimate the thyroid doses received by the American people from 131 I released by the nuclear weapons tests that were conducted at the Nevada Test Site in the 1950s. This study led to the assessment of doses from nuclear weapons tests conducted at other sites all over the world, as well as to a large number of dosimetry studies related to the Chernobyl nuclear reactor accident. He was the head of the Dosimetry Unit of the Radiation Epidemiology Branch at NCI until he retired at the end of 2010. Throughout his career, Dr. Bouville actively participated in the preparation of scientific reports under the umbrella of international organizations, notably the United Nations Scientific Committee on the Effects of Atomic Radiation, the International Commission on Radiological Protection, the International Commission on Radiation Units and Measurements, the World Health Organization, the International Atomic Energy Agency, and the Nuclear Energy Agency. Regarding U.S. organizations, Dr. Bouville was a member of NCRP for 12 y, became a Distinguished Emeritus Member in 2011, and is currently Chair of Scientific Committee 6-9 on the dosimetry for the Million Worker Study. He has served on numerous National Academy of Science committees, is a Lifetime Associate of the National Academies, and is currently a member of the Committee on the analysis of cancer risks in populations near nuclear facilities. For all his achievements, Dr. has been invited to China five times and to Japan seven times as a Visiting Lecturer and has had invited lectureships in 27 countries. In 1994 he was selected by the Chinese government as the President of the first International Congress on Birth Defects in China. Dr. Brent will receive the John Scott Award of the American Philosophical Society on November 22, 2013 for his research pertaining to the environmental causes of birth defects but especially for his early research that indicated that the embryo was less vulnerable to the carcinogenic effect of ionizing radiation than the child or adult.
Dr. Brent's greatest recognition has come from his research, publications and lecturing. He is the most frequently consulted authority on the effects of radiation on the embryo and is frequently consulted about other possible teratogenic exposures. His research on the effects of radiation on the embryo demonstrated the no-effect dose for congenital malformations, established that radiation effects on the embryo were due to the direct effects of the radiation, and demonstrated some of the characteristics of the "all-or-none period" of embryonic development.
His writings in the field of litigation concerning the proper role of an expert witness were important. As one of the defense experts in the Bendectin litigation, his testimony contributed to the famous Daubert decision that allowed judges to reject the testimony of junk scientists. His publications include six books and monographs, five movies, 458 publications, and over 400 abstracts. Jerrold T. Bushberg is the is the Senior Vice President of NCRP, and Clinical Professor of Radiology and Radiation Oncology, University of California (UC) Davis School of Medicine. He is an expert on the biological effects, safety, and interactions of ionizing and nonionizing radiation and holds multiple radiation detection technology patents. Dr. Bushberg is a fellow of the American Association of Physicist in Medicine and is certified by several national professional boards with specific subspecialty certification in radiation protection and medical physics. Prior to coming to the UC Davis Health System as technical director of nuclear medicine, Dr. Bushberg was on the faculty of Yale University School of Medicine where his research was focused on radiopharmaceutical development. Dr. Bushberg has served as an advisor to government agencies and institutions throughout the nation and around the world on the biological effects and safety of ionizing and nonionizing radiation exposure. He has worked for the U.S. Department of Homeland Security, the World Health Organization, and the International Atomic Energy Agency as a subject matter expert in radiation protection and radiological emergency medical management. Dr. Bushberg has responsibility for medical postgraduate education in medical physics, radiation (ionizing and nonionizing) protection, and radiation biology. The third edition of the textbook, The Essential Physics of Medical Imaging, authored by Bushberg, Seibert, Leidholdt, and Boone, is used extensively by radiology residency programs throughout the United States. 
S.Y. Chen is currently
